<p>Digital healthcare platform PharmEasy filed on Wednesday for an initial public offering (IPO) of up to Rs. 6,250-crore ($842.43 million), becoming the latest startup in the country to pursue a domestic stock listing.</p>.<p>The company provides health services ranging from teleconsultation to radiology tests to home delivery of medical products and devices.</p>.<p>For the three months ended June 30, the proforma gross merchandise value or the total monetary value of all sales for the company stood at Rs 3,026 crore.</p>.<p>API Holdings Ltd, PharmEasy's parent, may also consider a further issue of equity shares via a private placement of up to Rs 1,250 crore, the company said in its draft red herring prospectus dated Nov. 8.</p>.<p>The company counts technology-focused venture capital firm Naspers and entities related to global investment group CDPQ and private-equity firm TPG among its investors.</p>.<p>In a bid to diversify its operations, the firm had acquired Thyrocare Technologies, India's largest diagnostic test provider by volumes, in September.</p>.<p>PharmEasy's IPO filing comes on a day when Indian fashion e-commerce startup Nykaa is set to debut on stock exchanges, while fintech platform Paytm closes subscription prior to its debut.</p>.<p><strong>Check out DH's latest videos:</strong></p>.<p>Citigroup Global Markets India, JM Financial Ltd, Kotak Mahindra Capital, Morgan Stanley India and BoFA Securities India are joint bookrunners in API Holdings' IPO.</p>
<p>Digital healthcare platform PharmEasy filed on Wednesday for an initial public offering (IPO) of up to Rs. 6,250-crore ($842.43 million), becoming the latest startup in the country to pursue a domestic stock listing.</p>.<p>The company provides health services ranging from teleconsultation to radiology tests to home delivery of medical products and devices.</p>.<p>For the three months ended June 30, the proforma gross merchandise value or the total monetary value of all sales for the company stood at Rs 3,026 crore.</p>.<p>API Holdings Ltd, PharmEasy's parent, may also consider a further issue of equity shares via a private placement of up to Rs 1,250 crore, the company said in its draft red herring prospectus dated Nov. 8.</p>.<p>The company counts technology-focused venture capital firm Naspers and entities related to global investment group CDPQ and private-equity firm TPG among its investors.</p>.<p>In a bid to diversify its operations, the firm had acquired Thyrocare Technologies, India's largest diagnostic test provider by volumes, in September.</p>.<p>PharmEasy's IPO filing comes on a day when Indian fashion e-commerce startup Nykaa is set to debut on stock exchanges, while fintech platform Paytm closes subscription prior to its debut.</p>.<p><strong>Check out DH's latest videos:</strong></p>.<p>Citigroup Global Markets India, JM Financial Ltd, Kotak Mahindra Capital, Morgan Stanley India and BoFA Securities India are joint bookrunners in API Holdings' IPO.</p>